Imerio Angriman

Padova, 35128, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications

Ill Fate of Rectal Mucinous Adenocarcinoma: A Defect in Immunosurveillance or a Mucin Coating Effect?-The IMMUNOREACT 20 Study.

Ill Fate of Rectal Mucinous Adenocarcinoma: A Defect in Immunosurveillance or a Mucin Coating Effect?-The IMMUNOREACT 20 Study.

Journal: Cancers
Published: May 12, 2026

IMMUNOREACT 4: Peritumoral Microenvironment Associated with Anastomotic Leaks After Surgery for Rectal Cancer.

IMMUNOREACT 4: Peritumoral Microenvironment Associated with Anastomotic Leaks After Surgery for Rectal Cancer.

Journal: Cancers
Published: December 23, 2025

Postoperative Recurrence in Crohn's Disease: Pathophysiology, Risk Stratification, and Management Strategies.

Postoperative Recurrence in Crohn's Disease: Pathophysiology, Risk Stratification, and Management Strategies.

Journal: Journal of clinical medicine
Published: December 07, 2025

Advancing therapeutic frontiers: a pipeline of novel drugs for UC management.

Advancing therapeutic frontiers: a pipeline of novel drugs for UC management.

Journal: Frontiers in gastroenterology (Lausanne, Switzerland)
Published: November 15, 2025

Distinct microbiota composition and dendritic cell activation in the appendix microenvironment of ulcerative colitis patients.

Distinct microbiota composition and dendritic cell activation in the appendix microenvironment of ulcerative colitis patients.

Journal: Gut microbes
Published: August 19, 2025

Appendicectomy for ulcerative colitis.

Appendicectomy for ulcerative colitis.

Journal: The lancet. Gastroenterology & hepatology
Published: April 22, 2025

Oral administration of Lactobacillus casei DG® after ileostomy closure in restorative proctocolectomy: a randomized placebo-controlled trial (microbiota and immune microenvironment in pouchitis -MEP1).

Oral administration of Lactobacillus casei DG® after ileostomy closure in restorative proctocolectomy: a randomized placebo-controlled trial (microbiota and immune microenvironment in pouchitis -MEP1).

Journal: Gut microbes
Published: November 01, 2024

Advancing therapeutic frontiers: a pipeline of novel drugs for luminal and perianal Crohn's disease management.

Advancing therapeutic frontiers: a pipeline of novel drugs for luminal and perianal Crohn's disease management.

Journal: Therapeutic advances in gastroenterology
Published: July 12, 2024

IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancer.

IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancer.

Journal: Surgery
Published: June 10, 2024

Refractory Crohn's Disease: Perspectives, Unmet Needs and Innovations.

Refractory Crohn's Disease: Perspectives, Unmet Needs and Innovations.

Journal: Clinical and experimental gastroenterology
Published: June 03, 2024

Ileocaecal Crohn's disease. To resect or not to resect, is that the question?

Ileocaecal Crohn's disease. To resect or not to resect, is that the question?

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: April 24, 2024

Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications.

Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications.

Journal: Life (Basel, Switzerland)
Published: March 25, 2024
Showing 1-12 of 64

Last Updated: 09/26/2026